Join the ILTS Allied Health Committee webinar, Liver Injury Resulting from Herbals and Supplements, to explore the growing impact of supplement-related liver injury. This session will review key epidemiologic trends, highlight high-risk ingredients, and discuss practical approaches to management and prevention. Enhance your clinical insight and better equip yourself to identify and address this increasingly common challenge.
Webinar Objectives:
✅ To understand the epidemiology and clinical characteristics of liver injury from herbals and supplements.
✅ To identify ingredients that may be more likely to cause liver injury.
✅ To understand the management and prevention of liver injury from herbals and supplements.
Moderators:
Julie Corkrean
Director, Abdominal Transplant, J.C. Walter Jr. Transplant Center
Julie joined Houston Methodist Hospital in 2008 and currently serves as the Director of Abdominal Transplant Services. Before her time at Houston Methodist, she held positions in the field of transplant, including Manager of Solid Organ and BMT Transplant Services at Kaiser Permanente in Denver, Colorado. Prior to that, she worked as a Transplant Coordinator for the Kidney and Pancreas Transplant Program at UCLA. Julie began her nursing career as a travel nurse, specializing in acute dialysis. She holds a Bachelor of Science in Nursing from Montana State University and an MBA from Western Governor’s University.
Presentations & Speakers:
Liver Injury Resulting from Herbals and Supplements
Victor Navarro, MD Chief Clinical Officer, Jefferson Health System, Thomas Jefferson University
Dr. Victor Navarro is a Chief Clinical Officer for the Jefferson Health System, Thomas Jefferson University, Philadelphia, Pennsylvania, USA, and Professor of Medicine at Jefferson’s Sidney Kimmel Medical College. Dr. Navarro earned his Doctor of Medicine degree from the Pennsylvania State College of Medicine and completed medical residency followed by chief residency in Internal Medicine at Temple University Hospital, Philadelphia. Thereafter, he obtained fellowship training in Gastroenterology, Hepatology, and Hepatobiliary Endoscopy at Yale University after which he joined the faculty of the Yale University School of Medicine, New Haven, Connecticut. In 2002, Dr. Navarro assumed a full-time position as Chief of Hepatology and Medical Director for Liver Transplantation at Thomas Jefferson University Hospital, where he rose to the rank of Professor of Medicine, Pharmacology, and Experimental Therapeutics at the Jefferson Medical College, now the Sidney Kimmel Medical College. Dr. Navarro is funded by the National Institutes of Health (NIH/NIDDK) to study liver injury resulting from herbal and dietary supplements, and by the Patient Centered Outcomes Research Institute (PCORI) to study novel models for delivery of palliative care to patients with advanced stage liver disease.
Presented by
